<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Anisindione</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01125</strong>&#160; (APRD00799)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>Anisindione is a synthetic anticoagulant and an indanedione derivative. It prevents the formation of active procoagulation factors II, <span class="caps">VII</span>, IX, and X, as well as the anticoagulant proteins C and S, in the liver by inhibiting the vitamin K-mediated gamma-carboxylation of precursor proteins.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01125/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01125/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01125.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01125.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01125.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01125.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01125.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01125">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Anisin indandione</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Miradon</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Unidone</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>CAS number</th><td>117-37-3</td></tr><tr><th>Weight</th><td>Average: 252.2647<br>Monoisotopic: 252.07864425</td></tr><tr><th>Chemical Formula</th><td>C<sub>16</sub>H<sub>12</sub>O<sub>3</sub></td></tr><tr><th>InChI Key</th><td>XRCFXMGQEVUZFC-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C16H12O3/c1-19-11-8-6-10(7-9-11)14-15(17)12-4-2-3-5-13(12)16(14)18/h2-9,14H,1H3</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">2-(4-methoxyphenyl)-2,3-dihydro-1H-indene-1,3-dione</div></td></tr><tr><th>SMILES</th><td><div class="wrap">COC1=CC=C(C=C1)C1C(=O)C2=CC=CC=C2C1=O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Phenylpropanoids and Polyketides</td></tr><tr><th>Class</th><td>Stilbenes</td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Stilbenes</td></tr><tr><th>Alternative parents</th><td>Indanones; Anisoles; Alkyl Aryl Ethers; Ketones; Polyamines</td></tr><tr><th>Substituents</th><td>indanone; indane; phenol ether; anisole; alkyl aryl ether; benzene; ketone; ether; polyamine; carbonyl group</td></tr><tr><th>Classification description</th><td>This compound belongs to the stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups  to a phenyl ring lead to stilbenoids.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the prophylaxis and treatment of venous thrombosis and its extension, the treatment of atrial fibrillation with embolization, the prophylaxis and treatment of pulmonary embolism, and as an adjunct in the treatment of coronary occlusion.</td></tr><tr><th>Pharmacodynamics</th><td>Anisindione is a synthetic anticoagulant and an indanedione derivative. It is prescribed only if you cannot take coumarin-type anticoagulants such as coumadin as anisindione is a powerful drug with serious potential side effects. Anticoagulants decrease the clotting ability of the blood and therefore help to prevent harmful clots from forming in the blood vessels. These medicines are sometimes called blood thinners, although they do not actually thin the blood. They also will not dissolve clots that already have formed, but they may prevent the clots from becoming larger and causing more serious problems.</td></tr><tr><th>Mechanism of action</th><td>Like phenindione, to which it is related chemically, anisindione exercises its therapeutic action by reducing the prothrombin activity of the blood. Anisindione prevents the formation of active procoagulation factors II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver by inhibiting the vitamin K&#8211;mediated gamma-carboxylation of precursor proteins. Anisindione has no direct thrombolytic effect and does not reverse ischemic tissue damage, although it may limit extension of existing thrombi and prevent secondary thromboembolic complications.</td></tr><tr><th>Absorption</th><td>Accumulation does not occur with repeated dosing.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>Not Known</td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td>Not Known</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>An overdose is likely to cause abnormal bleeding, for which the symptoms include: bleeding from gums or nose, blood in urine or stools, excessive bleeding from minor cuts, patches of discoloration or bruises on the skin.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>1.0</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9051</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.8206</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.6289</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Inhibitor
        </td>
        <td>0.5099</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.534</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8467</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7584</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.8872</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.5965</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Inhibitor</td>
        <td>0.9594</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Inhibitor</td>
        <td>0.8996</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9457</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Inhibitor</td>
        <td>0.6234</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8639</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>High CYP Inhibitory Promiscuity</td>
        <td>0.6618</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          AMES toxic 
        </td>
        <td>
            0.6006
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.8733
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.8575
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.4052 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.944
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.8898
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Schering corp sub schering plough corp</li></ul></td></tr><tr><th>Packagers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Patents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>melting point</td><td>155-156</td><td>Sperber, N.; US. Patent 2,899,358; August 11, 1959; assigned to Schering Corporation</td></tr><tr><td>water solubility</td><td>79.8 mg/L</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>logP</td><td>2.88</td><td>SANGSTER (1993)</td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>1.28e-02 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>2.99</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>2.72</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-4.3</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest acidic)</td><td>4.5</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>pKa (strongest basic)</td><td>-4.8</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>-1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>3</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>43.37</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>71.7</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>26.3</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>3</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Sperber, N.; US. Patent 2,899,358; August 11, 1959; assigned to Schering Corporation</p></span></td></tr><tr><th>General Reference</th><td><span class="citations"><ol>
	<li><span class="caps">CONNELL</span> WF, <span class="caps">MAYER</span> GA: Evaluation of anticoagulant therapy with anisindione (miradon). Can Med Assoc J. 1959 May 15;80(10):785-90. <a href="http://www.ncbi.nlm.nih.gov/pubmed/13652026">Pubmed</a></li>
</ol></span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>PubChem Compound</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2197" target="_blank">2197 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Substance</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46504660" target="_blank">46504660 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChemSpider</td><td><a class="wishart-link-out" href="http://www.chemspider.com/Chemical-Structure.2112.html" target="_blank">2112 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEBI</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=133809" target="_blank">133809 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEMBL</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL712" target="_blank">CHEMBL712 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP001274" target="_blank">DAP001274 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA164746467" target="_blank">PA164746467 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>RxList</td><td><a class="wishart-link-out" href="http://www.rxlist.com/cgi/generic/miradon.htm" target="_blank">http://www.rxlist.com/cgi/generic/miradon.htm <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drugs.com</td><td><a class="wishart-link-out" href="http://www.drugs.com/pdr/anisindione.html" target="_blank">http://www.drugs.com/pdr/anisindione.html <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PDRhealth</td><td><a class="wishart-link-out" href="http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/mir1623.shtml" target="_blank">http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/mir1623.shtml <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Anisindione" target="_blank">Anisindione <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>AHFS Codes</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>MSDS</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00316">Acetaminophen</a></td><td>Acetaminophen increases the anticoagulant effect of anisindione. Monitor for changes in the therapeutic and adverse effects of anisindione if acetaminophen is initiated, discontinued or dose changed. </td></tr><tr><td><a href="/drugs/DB00945">Acetylsalicylic acid</a></td><td>Acetylsalicylic acid increases effect of the anticoagulant, anisindione.</td></tr><tr><td><a href="/drugs/DB00437">Allopurinol</a></td><td>Allopurinol may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00357">Aminoglutethimide</a></td><td>Aminoglutethimide may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01118">Amiodarone</a></td><td>Amiodarone may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00701">Amprenavir</a></td><td>Amprenavir may increase the anticoagulant effect of anisindione by increasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB00673">Aprepitant</a></td><td>Aprepitant may decrease the anticoagulant effect of anisindione by decreasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB01072">Atazanavir</a></td><td>The protease inhibitor, atazanavir, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00993">Azathioprine</a></td><td>Azathioprine may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00207">Azithromycin</a></td><td>Azithromycin may increase the anticoagulant effect of anisindione by increasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB00443">Betamethasone</a></td><td>The corticosteroid, betamethasone, alters the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00559">Bosentan</a></td><td>Bosentan may decrease the anticoagulant effect of anisindione by increasing its metabolism.</td></tr><tr><td><a href="/drugs/DB01101">Capecitabine</a></td><td>Capecitabine may increase the anticoagulant effect of anisindione by increasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>Carbamazepine may decrease the anticoagulant effect of anisindione by decreasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB01330">Cefotetan</a></td><td>The cephalosporin, cefotetan, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01331">Cefoxitin</a></td><td>The cephalosporin, cefoxitin, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01212">Ceftriaxone</a></td><td>The cephalosporin, ceftriaxone, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00482">Celecoxib</a></td><td>Celecoxib may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01432">Cholestyramine</a></td><td>The bile acid sequestrant, cholestyramine, may decrease the anticoagulant effect of anisindione by decreasing its absorption.</td></tr><tr><td><a href="/drugs/DB00501">Cimetidine</a></td><td>Cimetidine may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00537">Ciprofloxacin</a></td><td>The quinolone antibiotic, ciprofloxacin, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00604">Cisapride</a></td><td>Cisapride may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00215">Citalopram</a></td><td>The SSRI, citalopram, increases the effect of anticoagulant, anisindione.</td></tr><tr><td><a href="/drugs/DB01211">Clarithromycin</a></td><td>The macrolide, clarithromycin, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00636">Clofibrate</a></td><td>The fibrate increases the anticoagulant effect</td></tr><tr><td><a href="/drugs/DB00375">Colestipol</a></td><td>The bile acid sequestrant, colestipol, may decrease the anticoagulant effect of anisindione by decreasing its absorption.</td></tr><tr><td><a href="/drugs/DB00531">Cyclophosphamide</a></td><td>The antineoplastic agent, cyclophosphamide may alter the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01406">Danazol</a></td><td>The androgen, danazol, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00618">Demeclocycline</a></td><td>The tetracycline, demeclocycline, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01234">Dexamethasone</a></td><td>The corticosteroid, dexamethasone, alters the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00647">Dextropropoxyphene</a></td><td>Propoxyphene may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00509">Dextrothyroxine</a></td><td>The thyroid hormone, dextrothyroxine, increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00586">Diclofenac</a></td><td>The NSAID, diclofenac, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00485">Dicloxacillin</a></td><td>Dicloxacillin may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00861">Diflunisal</a></td><td>The NSAID, diflunisal, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00822">Disulfiram</a></td><td>Disulfiram may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00254">Doxycycline</a></td><td>The tetracycline, doxycycline, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00199">Erythromycin</a></td><td>The macrolide, erythromycin, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00189">Ethchlorvynol</a></td><td>Ethchlorvynol may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00977">Ethinyl Estradiol</a></td><td>Increased thrombotic risk due to estrogen</td></tr><tr><td><a href="/drugs/DB00749">Etodolac</a></td><td>The NSAID, etodolac, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01628">Etoricoxib</a></td><td>Etoricoxib may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01039">Fenofibrate</a></td><td>Fenofibrate may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00573">Fenoprofen</a></td><td>The NSAID, fenoprofen, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00196">Fluconazole</a></td><td>Fluconazole may increase the serum concentration of anisindione by decreasing its metabolism.</td></tr><tr><td><a href="/drugs/DB00687">Fludrocortisone</a></td><td>The corticosteroid, fludrocortisone, alters the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00544">Fluorouracil</a></td><td>The antineoplasic agent, fluorouracil, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00472">Fluoxetine</a></td><td>The SSRI, fluoxetine, increases the effect of anticoagulant, anisindione.</td></tr><tr><td><a href="/drugs/DB01185">Fluoxymesterone</a></td><td>The androgen, fluoxymesterone, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00712">Flurbiprofen</a></td><td>The NSAID, flurbiprofen, may increase the anticoagulant effect anisindione.</td></tr><tr><td><a href="/drugs/DB01095">Fluvastatin</a></td><td>Fluvastatin may increase the anticoagulant effect of anisindione. Monitor for changes in the therapeutic and adverse effects of anisindione if fluvastatin if initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00176">Fluvoxamine</a></td><td>Fluvoxamine may increase the anticoagulant effect of anisindione by increasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB01319">Fosamprenavir</a></td><td>The protease inhibitor, fosamprenavir, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>Increased hydantoin levels and risk of bleeding</td></tr><tr><td><a href="/drugs/DB00317">Gefitinib</a></td><td>Gefitinib may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00441">Gemcitabine</a></td><td>Gemcitabine may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01241">Gemfibrozil</a></td><td>Gemfibrozil may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01437">Glutethimide</a></td><td>Glutethimide may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00400">Griseofulvin</a></td><td>Griseofulvin may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00741">Hydrocortisone</a></td><td>The corticosteroid, hydrocortisone, alters the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01050">Ibuprofen</a></td><td>The NSAID, ibuprofen, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00619">Imatinib</a></td><td>Imatinib may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00224">Indinavir</a></td><td>The protease inhibitor, indinavir, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00328">Indomethacin</a></td><td>The NSAID, indomethacin, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00951">Isoniazid</a></td><td>Isoniazid may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01167">Itraconazole</a></td><td>Itraconazole may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01026">Ketoconazole</a></td><td>Ketoconazole may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01009">Ketoprofen</a></td><td>The NSAID, ketoprofen, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00465">Ketorolac</a></td><td>The NSAID, ketorolac, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01097">Leflunomide</a></td><td>Leflunomide may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00848">Levamisole</a></td><td>Levamisole may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01137">Levofloxacin</a></td><td>The quinolone antibiotic, levofloxacin, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00451">Levothyroxine</a></td><td>The thyroid hormone, levothyroxine, increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00227">Lovastatin</a></td><td>Lovastatin may increase the anticoagulant effect of anisindione. Monitor for changes in the therapeutic and adverse effects of anisindione if lovastatin if initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB01283">Lumiracoxib</a></td><td>Lumiracoxib may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00603">Medroxyprogesterone Acetate</a></td><td>Medroxyprogesterone may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00784">Mefenamic acid</a></td><td>The NSAID, mefanamic acid, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00358">Mefloquine</a></td><td>Mefloquine may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00814">Meloxicam</a></td><td>Meloxicam may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01033">Mercaptopurine</a></td><td>Mercaptopurine may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00763">Methimazole</a></td><td>The antithyroid agent, methimazole, may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00916">Metronidazole</a></td><td>Metronidazole may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01110">Miconazole</a></td><td>Miconazole may increase the serum concentration of anisindione by decreasing its metabolism.</td></tr><tr><td><a href="/drugs/DB01017">Minocycline</a></td><td>The tetracycline, minocycline, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00648">Mitotane</a></td><td>Mitotane may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00218">Moxifloxacin</a></td><td>The quinolone antibiotic, moxifloxacin, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00461">Nabumetone</a></td><td>The NSAID, nabumetone, may increase the anticoagulant effect anisindione.</td></tr><tr><td><a href="/drugs/DB00779">Nalidixic Acid</a></td><td>The quinolone antibiotic, nalidixic acid, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00788">Naproxen</a></td><td>The NSAID, naproxen, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00220">Nelfinavir</a></td><td>The protease inhibitor, nelfinavir, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00238">Nevirapine</a></td><td>Nevirapine may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01059">Norfloxacin</a></td><td>The quinolone antibiotic, norfloxacin, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01165">Ofloxacin</a></td><td>The quinolone antibiotic, ofloxacin, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01083">Orlistat</a></td><td>Orlistat may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00991">Oxaprozin</a></td><td>The NSAID, oxaprozin, may increase the anticoagulant effect of anisinodione.</td></tr><tr><td><a href="/drugs/DB03585">Oxyphenbutazone</a></td><td>The NSAID, oxyphenbutazone, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00715">Paroxetine</a></td><td>The SSRI, paroxetine, increases the effect of the anticoagulant, anisindione.</td></tr><tr><td><a href="/drugs/DB00806">Pentoxifylline</a></td><td>Pentoxifylline may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01174">Phenobarbital</a></td><td>The barbiturate, phenobarbital, decreases the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00812">Phenylbutazone</a></td><td>The NSAID, phenylbutazone, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>Increased hydantoin levels and risk of bleeding</td></tr><tr><td><a href="/drugs/DB00554">Piroxicam</a></td><td>The NSAID, piroxicam, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00860">Prednisolone</a></td><td>The corticosteroid, prednisolone, alters the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00635">Prednisone</a></td><td>The corticosteroid, prednisone, alters the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00794">Primidone</a></td><td>The barbiturate, primidone, decreases the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01182">Propafenone</a></td><td>Propafenone may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00550">Propylthiouracil</a></td><td>The anti-thyroid agent, propylthiouracil, may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00908">Quinidine</a></td><td>Quinidine may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00468">Quinine</a></td><td>Quinine may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00863">Ranitidine</a></td><td>Ranitidine may increase the anticoagulant effect of anisindione. (Conflicting evidence)</td></tr><tr><td><a href="/drugs/DB00615">Rifabutin</a></td><td>Rifabutin, may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01045">Rifampicin</a></td><td>Rifampin may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00976">Telithromycin</a></td><td>Telithromycin may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00469">Tenoxicam</a></td><td>The NSAID, tenoxicam, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00624">Testosterone</a></td><td>The androgen may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00759">Tetracycline</a></td><td>Tetracycline may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00560">Tigecycline</a></td><td>Tigecycline may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00620">Triamcinolone</a></td><td>The corticosteroid, triamcinolone, alters the anticoagulant effect of anisindione.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>